The Self-Regulation Panel: Taking Care Of (Our Own) Business

by | Jul 25, 2018

Panel Discussion

The government has its standards. But to stake its identity, the industry must self-regulate. And it’s responding on multiple fronts, adding consumer-first issues like quality claims and standards to the government’s priority of safety issues. There’s the CannabisWise certification, a voluntary testing program announced by the National Institute for Cannabis Health and Education. And with an eye on the world market, testers are seeking ISO/IEC 17025 accreditation, from the International Organization for Standardization. There’s even an emerging GQA (Growers Quality Assurance) based on the wine industry’s Vintners Quality Alliance (VQA). This panel features key players in quality control and testing, who envision a future where “buyer beware” is not an option.

Moderator: Barinder Rasode, Niche Canada

 

How the Cannabis Act and the Legalization of Marijuana Affect Travel to the US

by | Jul 25, 2018

Presentation

This session will explore the criminal and immigration ramifications to those working in the cannabis industry, when entering the US or Canada.

In particular we will discuss:

• What will the impact of the new marijuana legislation on legalization on travel to the United States and Canada?

• What happens now if you are asked about whether you have used marijuana in the past?

• What can you do if found criminally inadmissible in Canada or the US because of pot use or DUI?

• How do the new laws affect those who are associated with the marijuana industry?

 

 

 

Cannabis: An Exit Drug

Cannabis: An Exit Drug

by | Jul 25, 2018

Presentation

  • Former BC Health Minister and current Vice-President of Corporate and Social Responsibility at HEXO, Dr. Lake will discuss the critical role of legal cannabis for managing the opioid crisis.

Brought to you by

[one_second][/one_second] [one_second]  [/one_second]

Based in Quebec, Hydropothecary / HEXO creates and distributes innovative, easy-to-use and easy-to-understand products to serve the Canadian cannabis market. One of the country’s lowest-cost producers, HEXO is rapidly increasing its production capacity in the lead up to the adult-use cannabis market. The Company currently operates with 310,000 sq. ft. of production capacity with construction on another 1,000,000 sq. ft. expansion set to be complete by year end. HEXO will serve the adult-use market under the HEXO brand, while continuing to serve its medical cannabis clients through the well-known Hydropothecary brand.  

 

Best HIGH for Cannabis Companies? Strong IP Protection

by | Jul 25, 2018

Presentation

The impending legalization of cannabis will increase the market value substantially. As a result, it is increasingly important that companies producing cannabis, cannabis products and devices seek to protect their Intellectual Property (IP) in Canada in order to increase their market share.

This session will focus on the protection of cannabis and related products through patents and Plant Breeders’ Rights(PBRs). A patent is a very important asset as it provides a monopoly to the owner to exclude others from making, using or selling the invention during the term of the patent, which is 20 years from the filing date. The session will discuss the types of cannabis related products that can be protected by patents. Plant Breeders’ Rights are also important as they give the cannabis breeder the exclusive rights to the propagating material of their novel cannabis variety for a period of 20 years including the right to sell, produce and reproduce, import and export propagating material of the variety as well as the right to authorize others to do the same.  Both patents and PBRs have very specific timing requirements and missing critical deadlines can put your rights up in smoke.